Dhanvantri Jeevan Rekha News

Dhanvantri Jeevan Rekha Board Meet on May 28

Dhanvantri Jeevan Rekha Ltd. has scheduled a Board of Directors meeting on May 28, 2026, to consider audited financial results for Q4 and full year ended March 31, 2026.

Dhanvantri Jeevan Rekha Files SEBI Compliance Certificate

Dhanvantri Jeevan Rekha Limited submitted its quarterly certificate under SEBI Regulation 74(5) for Q4 FY26, confirming compliance with dematerialization requirements through registrar Beetal Financial.

Dhanvantri Jeevan Rekha Reports Net Loss and Negative Cash Flow in Latest Results

Dhanvantri Jeevan Rekha Limited posted a net loss of Rs. 7.68 lacs with negative earnings per share of Rs. 0.34 for the quarter ended September 30, 2025. The company experienced significant cash outflow of Rs. 140.09 lacs and declining cash reserves from Rs. 254.52 lacs to Rs. 114.43 lacs during the six-month period.

Dhanvantri Jeevan Rekha Limited Reports Quarterly Financial Results for June 2025

Dhanvantri Jeevan Rekha Limited's Board of Directors approved unaudited financial results for the quarter and year ended June 30, 2025, during a board meeting held on August 13, 2025. The company reported net sales of Rs 551 lakhs for the quarter, compared to Rs 583 lakhs in the previous quarter and Rs 570 lakhs in the same quarter last year. Total income for the quarter was Rs 558 lakhs. The company posted a profit of Rs 5 lakhs for the quarter, down from Rs 3 lakhs in the previous quarter but lower than Rs 16 lakhs in the corresponding quarter of the previous year. Basic and diluted earnings per share stood at Rs 0.15 for the quarter. Total expenses were Rs 552 lakhs, with other expenses being the largest component at Rs 282 lakhs. The company operates Dhanvantri Hospital and has its paid-up equity share capital of Rs 410 lakhs with face value of Rs 10 per share. The results will be published in newspapers and are available on the company's website and BSE's website.